journal article·2025-03-10Open access

Multifunctional DNA-Collagen Biomaterials: Developmental Advances and Biomedical Applications

Nikolaos Pipis, Bryan D. James, Josephine B. Allen

Abstract

The complexation of nucleic acids and collagen forms a platform biomaterial greater than the sum of its parts. This union of biomacromolecules merges the extracellular matrix functionality of collagen with the designable bioactivity of nucleic acids, enabling advances in regenerative medicine, tissue engineering, gene delivery, and targeted therapy. This review traces the historical foundations and critical applications of DNA-collagen complexes and highlights their capabilities, demonstrating them as biocompatible, bioactive, and tunable platform materials. These complexes form structures across length scales, including nanoparticles, microfibers, and hydrogels, a process controlled by the relative amount of each component and the type of nucleic acid and collagen. The broad distribution of different types of collagen within the body contributes to the extensive biological relevance of DNA-collagen complexes. Functional nucleic acids can form these complexes, such as siRNA, antisense oligonucleotides, DNA origami nanostructures, and, in particular, single-stranded DNA aptamers, often distinguished by their rapid self-assembly at room temperature and formation without external stimuli and modifications. The simple and seamless integration of nucleic acids within collagenous matrices enhances biomimicry and targeted bioactivity, and provides stability against enzymatic degradation, positioning DNA-collagen complexes as an advanced biomaterial system for many applications including angiogenesis, bone tissue regeneration, wound healing, and more.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

J. Crayton Pruitt Family Department of Biomedical Engineering

University of Florida

Department of Chemical Engineering

Northeastern University

Department of Materials Science & Engineering

Funding

National Institute of General Medical Sciences

References (100+)

Show source-provided references
1. 10.1016/j.progpolymsci.2015.02.00410.1016/j.progpolymsci.2015.02.004 ↗
2. 10.3390/biom1302028010.3390/biom13020280 ↗
3. 10.1002/app.5037610.1002/app.50376 ↗
4. 10.3390/polym1211270210.3390/polym12112702 ↗
5. 10.1007/s13346-021-00970-110.1007/s13346-021-00970-1 ↗
6. 10.1093/brain/awp24010.1093/brain/awp240 ↗
7. 10.1163/156856208X38638110.1163/156856208X386381 ↗
8. 10.3390/molecules2709290210.3390/molecules27092902 ↗
9. 10.1002/asia.20220079710.1002/asia.202200797 ↗
10. 10.1016/j.carbpol.2023.12079010.1016/j.carbpol.2023.120790 ↗
11. 10.1016/j.mtbio.2021.10009810.1016/j.mtbio.2021.100098 ↗
12. Silver F. H. · J. Long Term Eff Med. Implants · 1992 · 2 · 67
13. 10.3390/polym1405098610.3390/polym14050986 ↗
14. 10.1016/j.polymdegradstab.2016.06.01510.1016/j.polymdegradstab.2016.06.015 ↗
15. 10.1002/jbm.a.3089310.1002/jbm.a.30893 ↗
16. 10.1021/acsbiomaterials.2c0073010.1021/acsbiomaterials.2c00730 ↗
17. 10.1186/s12938-019-0647-010.1186/s12938-019-0647-0 ↗
18. Allen, J.; Ramaswamy, V.; Dulany, K.; Goins, A. N. Aldehyde Crosslinking, Protein Based Tissue Scaffolds, and Uses Thereof. US20210388164A1, December 16, 2021. https://patents.google.com/patent/US20210388164A1/en.
19. 10.3390/pharmaceutics1306083210.3390/pharmaceutics13060832 ↗
20. 10.1038/nmat174110.1038/nmat1741 ↗
21. 10.1039/C5CS00586H10.1039/C5CS00586H ↗
22. 10.1021/jacs.3c0780210.1021/jacs.3c07802 ↗
23. 10.1002/adfm.20190625310.1002/adfm.201906253 ↗
24. 10.1098/rsfs.2016.014110.1098/rsfs.2016.0141 ↗
25. 10.1002/cbic.20230042310.1002/cbic.202300423 ↗
26. 10.1021/acsbiomaterials.0c0112510.1021/acsbiomaterials.0c01125 ↗
27. 10.3390/app1104188510.3390/app11041885 ↗
28. 10.1038/nmeth.291810.1038/nmeth.2918 ↗
29. 10.1002/mabi.20200033710.1002/mabi.202000337 ↗
30. 10.1002/wnan.173110.1002/wnan.1731 ↗
31. 10.1038/nrd314110.1038/nrd3141 ↗
32. 10.2174/09298671179718960010.2174/092986711797189600 ↗
33. 10.1021/acsbiomaterials.1c0154410.1021/acsbiomaterials.1c01544 ↗
34. Lake R. A. · Immunology · 1985 · 54 · 389
35. 10.1038/ki.1992.24210.1038/ki.1992.242 ↗
36. 10.1084/jem.147.3.68410.1084/jem.147.3.684 ↗
37. Emlen W. · Clin. Exp. Immunol. · 1984 · 56 · 185
38. 10.4049/jimmunol.154.5.242410.4049/jimmunol.154.5.2424 ↗
39. 10.1084/jem.144.2.42810.1084/jem.144.2.428 ↗
40. Rosenberg A. M. · J. Rheumatol. · 1986 · 13 · 512
41. 10.1002/anr.178032031110.1002/anr.1780320311 ↗
42. 10.1016/0896-8411(88)90029-710.1016/0896-8411(88)90029-7 ↗
43. Rosenberg A. M. · J. Rheumatol. · 1983 · 10 · 925
44. 10.4049/jimmunol.135.2.109710.4049/jimmunol.135.2.1097 ↗
45. 10.4049/jimmunol.144.9.348410.4049/jimmunol.144.9.3484 ↗
46. 10.1002/art.178031040110.1002/art.1780310401 ↗
47. 10.1016/j.ijbiomac.2005.02.00410.1016/j.ijbiomac.2005.02.004 ↗
48. 10.1016/S0141-8130(97)00021-410.1016/S0141-8130(97)00021-4 ↗
49. 10.1016/j.ijbiomac.2004.11.00510.1016/j.ijbiomac.2004.11.005 ↗
50. 10.1006/bbrc.2001.613310.1006/bbrc.2001.6133 ↗
51. 10.1016/j.ijbiomac.2012.06.03910.1016/j.ijbiomac.2012.06.039 ↗
52. 10.1021/jacs.7b0808710.1021/jacs.7b08087 ↗
53. 10.1021/bm700881310.1021/bm7008813 ↗
54. 10.1016/j.jtbi.2008.09.01310.1016/j.jtbi.2008.09.013 ↗
55. 10.1021/acsbiomaterials.9b0143510.1021/acsbiomaterials.9b01435 ↗
56. 10.1016/j.msec.2020.11168310.1016/j.msec.2020.111683 ↗
57. 10.1021/acsomega.4c0410410.1021/acsomega.4c04104 ↗
58. 10.1002/advs.20210369310.1002/advs.202103693 ↗
59. 10.2174/156802662166621121514291610.2174/1568026621666211215142916 ↗
60. 10.1039/9781839161148-0045910.1039/9781839161148-00459 ↗
61. 10.1073/pnas.050175310210.1073/pnas.0501753102 ↗
62. 10.1093/nar/gnh09310.1093/nar/gnh093 ↗
63. 10.1196/annals.1348.01010.1196/annals.1348.010 ↗
64. 10.1093/nar/25.11.218210.1093/nar/25.11.2182 ↗
65. 10.1016/j.ijbiomac.2005.11.00810.1016/j.ijbiomac.2005.11.008 ↗
66. 10.1021/jp307379810.1021/jp3073798 ↗
67. 10.1039/D0SM00543F10.1039/D0SM00543F ↗
68. 10.1002/cbic.20210003010.1002/cbic.202100030 ↗
69. 10.1016/j.bios.2014.09.06010.1016/j.bios.2014.09.060 ↗
70. 10.2174/157016304333483910.2174/1570163043334839 ↗
71. 10.1126/science.aat614110.1126/science.aat6141 ↗
72. 10.1002/adma.20180638010.1002/adma.201806380 ↗
73. Saenz, S.; James, B. D.; Allen, J. B. Nucleic Acid Elastin Collagen Complex (NAECC) Fibers and Gels Working Towards an ECM Mimic, https://abstracts.biomaterials.org/data/papers/2021/abstracts/56.pdf.
74. 10.1039/D4TB00287C10.1039/D4TB00287C ↗
75. 10.1038/956010.1038/9560 ↗
76. 10.1016/j.ijbiomac.2019.03.09210.1016/j.ijbiomac.2019.03.092 ↗
77. Toyama Y. · Trans. Mater. Res. Soc. Jpn. · 2003 · 28 · 941
78. 10.1016/j.ijbiomac.2005.07.00610.1016/j.ijbiomac.2005.07.006 ↗
79. 10.1089/hum.1998.9.12-170910.1089/hum.1998.9.12-1709 ↗
80. 10.1021/acs.nanolett.3c0449710.1021/acs.nanolett.3c04497 ↗
81. 10.1021/acsabm.2c0082810.1021/acsabm.2c00828 ↗
82. 10.1002/chem.20170097110.1002/chem.201700971 ↗
83. Guerin, P.; James, B. D.; Allen, J. B. Nucleic Acid-Collagen Complexes (NACCs) Stabilization via Physiological Ions, https://abstracts.biomaterials.org/data/papers/2021/abstracts/55.pdf.
84. 10.3389/fchem.2023.110740010.3389/fchem.2023.1107400 ↗
85. 10.3390/ijms24191499010.3390/ijms241914990 ↗
86. 10.1007/s40883-024-00345-110.1007/s40883-024-00345-1 ↗
87. Maleckis, K. Mechanical Properties and Structure of DNA and Collagen Nanofilaments. Embargoed Master’s Theses 2012. https://digitalcommons.unl.edu/embargotheses/33/.
88. Yadavalli, V. K.; Pidaparti, R. M. Nanocomposites Based on Self-Assembly of Collagen with DNA. 2009, 2. https://briefs.techconnect.org/wp-content/volumes/Nanotech2009v2/pdf/638.pdf.
89. 10.1039/C3RA46618C10.1039/C3RA46618C ↗
90. 10.1126/science.adn569410.1126/science.adn5694 ↗
91. 10.1254/jphs.FP004050410.1254/jphs.FP0040504 ↗
92. 10.1039/C9RA03198G10.1039/C9RA03198G ↗
93. 10.1002/adma.20140335410.1002/adma.201403354 ↗
94. 10.1073/pnas.191489911710.1073/pnas.1914899117 ↗
95. 10.1016/j.atherosclerosis.2017.03.00510.1016/j.atherosclerosis.2017.03.005 ↗
96. 10.1021/cr800443h10.1021/cr800443h ↗
97. 10.1016/j.mser.2007.05.00110.1016/j.mser.2007.05.001 ↗
98. 10.1016/j.actbio.2011.04.01410.1016/j.actbio.2011.04.014 ↗
99. 10.1016/j.jsb.2013.04.00310.1016/j.jsb.2013.04.003 ↗
100. 10.1021/acsbiomaterials.9b0184110.1021/acsbiomaterials.9b01841 ↗